Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.
Cancers (Basel)
; 10(10)2018 Oct 05.
Article
in En
| MEDLINE
| ID: mdl-30301187
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Diagnostic_studies
Language:
En
Journal:
Cancers (Basel)
Year:
2018
Document type:
Article
Affiliation country:
Austria
Country of publication:
Switzerland